CL2011000065A1 -
Veterinary formulation for the prevention and elimination of infection by strains of e. coli stec, which comprises a recombinant plasmid encoding a virulence factor and cationic liposome as a vehicle, use of said formulation to preferably treat cattle and pigs.
- Google Patents
Veterinary formulation for the prevention and elimination of infection by strains of e. coli stec, which comprises a recombinant plasmid encoding a virulence factor and cationic liposome as a vehicle, use of said formulation to preferably treat cattle and pigs.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ ConcepcionfiledCriticalUniv Concepcion
Priority to CL2011000065ApriorityCriticalpatent/CL2011000065A1/en
Publication of CL2011000065A1publicationCriticalpatent/CL2011000065A1/en
Formulación veterinaria para la prevención y eliminación de infección por cepas de E. Coli Stec, que comprende un plásmido recombinante que codifica el factor de virulencia Efa A1 y liposoma catiónico como vehículo, uso de dicha formulación para tratar preferentemente bovinos y porcinos.Veterinary formulation for the prevention and elimination of infection by strains of E. Coli Stec, which comprises a recombinant plasmid encoding the Efa A1 virulence factor and cationic liposome as a vehicle, use of said formulation to preferably treat cattle and pigs.
CL2011000065A2011-01-112011-01-11
Veterinary formulation for the prevention and elimination of infection by strains of e. coli stec, which comprises a recombinant plasmid encoding a virulence factor and cationic liposome as a vehicle, use of said formulation to preferably treat cattle and pigs.
CL2011000065A1
(en)
Veterinary formulation for the prevention and elimination of infection by strains of e. coli stec, which comprises a recombinant plasmid encoding a virulence factor and cationic liposome as a vehicle, use of said formulation to preferably treat cattle and pigs.
Veterinary formulation for the prevention and elimination of infection by strains of e. coli stec, which comprises a recombinant plasmid encoding a virulence factor and cationic liposome as a vehicle, use of said formulation to preferably treat cattle and pigs.
Veterinary formulation for the prevention and elimination of infection by strains of e. coli stec, which comprises a recombinant plasmid encoding a virulence factor and cationic liposome as a vehicle, use of said formulation to preferably treat cattle and pigs.
Chewable veterinary composition comprising as active agent an isoxazoline derivative compound; and its use for the treatment and / or prevention of an infestation and / or infection by parasites in an animal.
Autotaxin inhibitor compounds; pharmaceutical composition and combination; and use in the treatment of diseases such as fibrosis, pruritus, cancer, among others.
Aqueous acid formulation comprising a first fluorocarbon linked peptide; method to obtain said formulation; use of said formulation to treat or prevent pathogenic infection, an autoimmune disease or cancer.
Avirulent modified salmonella gallinarum strains; pharmaceutical composition that use it; feed additive; procedure for the treatment of infectious avian typhosis by salmonella gallinarum.
Peptides with antimicrobial activity, medicinal compositions for the treatment and prophylaxis of animals, compositions for the treatment and prophylaxis of plants, uses of the so-called peptides and uses of the extract of paenibacillus elgii ourofinensis
Veterinary formulation for the prevention and elimination of infection by strains of e. coli stec, which comprises a recombinant plasmid encoding a virulence factor and cationic liposome as a vehicle, use of said formulation to preferably treat cattle and pigs.